104 related articles for article (PubMed ID: 18623087)
1. The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells.
Ruiz A; Williams O; Brady HJ
Int J Cancer; 2008 Sep; 123(6):1240-5. PubMed ID: 18623087
[TBL] [Abstract][Full Text] [Related]
2. A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells.
Beer PA; Knapp DJ; Kannan N; Miller PH; Babovic S; Bulaeva E; Aghaeepour N; Rabu G; Rostamirad S; Shih K; Wei L; Eaves CJ
Stem Cell Reports; 2014 Nov; 3(5):841-57. PubMed ID: 25418728
[TBL] [Abstract][Full Text] [Related]
3. Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.
von Palffy S; Bulaeva E; Babovic S; Kannan N; Knapp DJ; Wei L; Eaves CJ; Beer PA
Exp Hematol; 2015 Jul; 43(7):514-23.e1-2. PubMed ID: 25951974
[TBL] [Abstract][Full Text] [Related]
4. Forced expression of the Ikaros 6 isoform in human placental blood CD34(+) cells impairs their ability to differentiate toward the B-lymphoid lineage.
Tonnelle C; Bardin F; Maroc C; Imbert AM; Campa F; Dalloul A; Schmitt C; Chabannon C
Blood; 2001 Nov; 98(9):2673-80. PubMed ID: 11675337
[TBL] [Abstract][Full Text] [Related]
5. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival.
Ruiz A; Jiang J; Kempski H; Brady HJ
Br J Haematol; 2004 Apr; 125(1):31-7. PubMed ID: 15015965
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
8. IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cells.
Suzuki K; Ono R; Ohishi K; Masuya M; Kataoka I; Liu B; Nakamori Y; Ino K; Monma F; Hamada H; Kitamura T; Katayama N; Nosaka T
Int J Oncol; 2012 Jan; 40(1):53-62. PubMed ID: 21901249
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.
Ezzat S; Zhu X; Loeper S; Fischer S; Asa SL
Mol Endocrinol; 2006 Nov; 20(11):2976-86. PubMed ID: 16873443
[TBL] [Abstract][Full Text] [Related]
10. Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.
Beer PA; Knapp DJ; Miller PH; Kannan N; Sloma I; Heel K; Babovic S; Bulaeva E; Rabu G; Terry J; Druker BJ; Loriaux MM; Loeb KR; Radich JP; Erber WN; Eaves CJ
Blood; 2015 Jan; 125(3):504-15. PubMed ID: 25370416
[TBL] [Abstract][Full Text] [Related]
11. Ikaros isoform x is selectively expressed in myeloid differentiation.
Payne KJ; Huang G; Sahakian E; Zhu JY; Barteneva NS; Barsky LW; Payne MA; Crooks GM
J Immunol; 2003 Mar; 170(6):3091-8. PubMed ID: 12626565
[TBL] [Abstract][Full Text] [Related]
12. High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis.
Yagi T; Hibi S; Takanashi M; Kano G; Tabata Y; Imamura T; Inaba T; Morimoto A; Todo S; Imashuku S
Blood; 2002 Feb; 99(4):1350-5. PubMed ID: 11830486
[TBL] [Abstract][Full Text] [Related]
13. Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels.
Kano G; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Inaba T; Yagi T; Imashuku S
Leuk Lymphoma; 2008 May; 49(5):965-73. PubMed ID: 18464116
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ikaros isoform 6 in chinese children with acute lymphoblastic leukemia.
Zhou F; Mei H; Jin R; Li X; Chen X
J Pediatr Hematol Oncol; 2011 Aug; 33(6):429-32. PubMed ID: 21792038
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen.
Tonnelle C; Imbert MC; Sainty D; Granjeaud S; N'Guyen C; Chabannon C
Hematol J; 2003; 4(2):104-9. PubMed ID: 12750728
[TBL] [Abstract][Full Text] [Related]
16. Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.
Ezzat S; Yu S; Asa SL
Am J Pathol; 2003 Sep; 163(3):1177-84. PubMed ID: 12937159
[TBL] [Abstract][Full Text] [Related]
17. Alteration in Ikaros expression promotes B-1 cell differentiation into phagocytes.
Oliveira VC; Sodré ACP; Gomes CP; Moretti NS; Pesquero JB; Popi AF
Immunobiology; 2018 Feb; 223(2):252-257. PubMed ID: 29107383
[TBL] [Abstract][Full Text] [Related]
18. Expression of Ik6 and Ik8 Isoforms and Their Association with Relapse and Death in Mexican Children with Acute Lymphoblastic Leukemia.
Reyes-León A; Juárez-Velázquez R; Medrano-Hernández A; Cuenca-Roldán T; Salas-Labadía C; Del Pilar Navarrete-Meneses M; Rivera-Luna R; López-Hernández G; Paredes-Aguilera R; Pérez-Vera P
PLoS One; 2015; 10(7):e0130756. PubMed ID: 26131904
[TBL] [Abstract][Full Text] [Related]
19. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides AP; Dobson SM; Laurenti E; Notta F; Voisin V; Cheng PY; Yuan JS; Guidos CJ; Minden MD; Mullighan CG; Torlakovic E; Dick JE
Leukemia; 2015 Jan; 29(1):177-87. PubMed ID: 24791856
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
